Acorda Therapeutics Inc (NASDAQ:ACOR) traded at $1.02 at close of the session on Tuesday, April 09, made a downward move of -15.00% on its previous day’s price.
Looking at the stock we see that its previous close was $1.20 and the beta (5Y monthly) reads 1.42 . In terms of its 52-week price range, ACOR has a high of $24.20 and a low of $1.12. The company’s stock has lost about -92.03% over that past 30 days.
Acorda Therapeutics Inc has a market cap of $1.26 million and is expected to release its quarterly earnings report on May 02, 2024 – May 06, 2024.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the ACOR stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is -89.67% off its SMA20 and -92.01% from its 50-day simple moving average. The RSI (14) is pointing at 17.45 while the volatility over the past week is 21.31% and jumps to 16.26% over the past one month. The beta value is 1.57, while the average true range (ATR) is currently pointing at 1.20.
Coming back to Acorda Therapeutics Inc (NASDAQ:ACOR), we note that the average 3-month trading volume was 99.43K, while that of the preceding 10-day period stands at 0.58 million. Current shares outstanding are 1.24 million.
The insiders hold 0.69% of the company’s shares while institutions hold 12.71%. The data shows that short shares as of Mar 15, 2024, stood at 9460.0 at a short ratio of 2.21. This represents a 0.76% short interest in shares outstanding on Mar 15, 2024. Shares short fall in March from the previous month at 10250.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -93.24% down in year-to-date price movement.
